Filing metadata

Accession number
0001415889-24-024701
Form type
Form 4
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
Oct 03, 2024
Reporting period
Oct 01, 2024
Description
Insider transaction

Explore SEC Filings Hub